Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 1)

Anemia (Phase 2)

Anemia, Aplastic (Phase 2)

Anemia, Diamond-Blackfan (Phase 2)

Anemia, Sickle Cell (Phase 2)

Disease (Phase 1)

Fanconi Anemia (Phase 2)

Graft vs Host Disease (Phase 2)

Hematologic Neoplasms (Phase 1)

Hemoglobinopathies (Phase 2)

Immune System Diseases (Phase 1)

Immunologic Deficiency Syndromes (Phase 2)

Immunoproliferative Disorders (Phase 1)

Leukemia (Phase 2)

Leukemia, Biphenotypic, Acute (Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myelomonocytic, Chronic (Phase 1)

Leukemia, Myelomonocytic, Juvenile (Phase 1)

Lymphatic Diseases (Phase 1)

Lymphohistiocytosis, Hemophagocytic (Phase 1)

Lymphoma (Phase 1)

Lymphoma, B-Cell (Phase 1)

Lymphoma, Non-Hodgkin (Phase 2)

Melanoma (Phase 1)

Metabolic Diseases (Phase 1)

Multiple Myeloma (Phase 1)

Myelodysplastic-Myeloproliferative Diseases (Phase 1)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 2)

Neoplasms (Phase 2)

Osteopetrosis (Phase 2)

Pancytopenia (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Preleukemia (Phase 1)

Prostatic Neoplasms (Phase 1)

Stomach Neoplasms (Phase 1)

Suicide (Phase 2)

Thalassemia (Phase 2)

Uveal Neoplasms (Phase 1)